v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 19,264 $ 65,116
Restricted cash, current 503 519
Short-term investments 54,194 0
Financial assets:    
Accounts receivable 11,920 10,036
Contract assets 4,375 815
Unbilled receivables 2,751 9,142
Total financial assets 19,046 19,993
Less: allowances (162) (65)
Total financial assets, net 18,884 19,928
Inventories 1,799 2,685
Prepaid expenses and other current assets 4,128 5,218
Total current assets 98,772 93,466
Restricted cash 1,062 1,062
Investment in non-marketable equity securities 2,798 9,700
Right-of-use assets - Operating leases, net 28,700 13,137
Property and equipment, net 14,197 15,487
Goodwill 2,463 2,463
Other non-current assets 1,019 1,246
Total assets 149,011 136,561
Current liabilities:    
Accounts payable 2,838 5,947
Accrued compensation 11,410 11,246
Other accrued liabilities 6,223 4,735
Current portion of lease obligations - Operating leases 2,827 3,781
Deferred revenue 350 10,121
Total current liabilities 23,648 35,830
Deferred revenue, net of current portion 100 640
Long-term lease obligations - Operating leases 28,163 12,243
Long-term debt 28,905 0
Other long-term liabilities 1,268 1,233
Total liabilities 82,084 49,946
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Preferred stock, $0.0001 par value per share; 5,000 shares authorized, none issued and outstanding 0 0
Common stock, $0.0001 par value per share; 200,000 shares authorized; 81,850 and 69,905 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively 8 7
Additional paid-in capital 629,673 584,138
Accumulated other comprehensive income 52 0
Accumulated deficit (562,806) (497,530)
Total stockholders’ equity 66,927 86,615
Total liabilities and stockholders’ equity $ 149,011 $ 136,561

Source

PDF HTML 10-K Filing
ZIP XBRL